United States (US) Pharmaceutical Serialization Market (2025-2031) | Segmentation, Competitive Landscape, Size & Revenue, Outlook, Forecast, Share, Companies, Analysis, Value, Growth, Trends, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Pharmaceutical Serialization Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Pharmaceutical Serialization Market - Industry Life Cycle

3.4 United States (US) Pharmaceutical Serialization Market - Porter's Five Forces

3.5 United States (US) Pharmaceutical Serialization Market Revenues & Volume Share, By Packaging Format, 2021 & 2031F

3.6 United States (US) Pharmaceutical Serialization Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 United States (US) Pharmaceutical Serialization Market Revenues & Volume Share, By End-Use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Implementation of stringent regulations by the FDA requiring serialization and track-and-trace systems in the pharmaceutical industry.

4.2.2 Increasing cases of counterfeit drugs in the market, driving the need for serialization to ensure product authenticity.

4.2.3 Growing focus on patient safety and drug traceability, leading to the adoption of serialization technologies in the pharmaceutical supply chain.

4.3 Market Restraints

4.3.1 High initial investment costs associated with implementing serialization solutions.

4.3.2 Complexity in integrating serialization systems with existing manufacturing and supply chain processes.

4.3.3 Concerns regarding data security and privacy in maintaining serialization data across the supply chain.

6.1 United States (US) Pharmaceutical Serialization Market, By Packaging Format

6.1.1 Overview and Analysis

6.1.2 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Packaging Format, 2021- 2031F

6.1.3 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Bottles & Jars, 2021- 2031F

6.1.4 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Vials & Ampoules, 2021- 2031F

6.1.5 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Blisters, 2021- 2031F

6.1.6 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Trays, 2021- 2031F

6.1.7 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Pouches & Sachets, 2021- 2031F

6.1.8 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Others (tubes, etc.), 2021- 2031F

6.2 United States (US) Pharmaceutical Serialization Market, By Technology

6.2.1 Overview and Analysis

6.2.2 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Barcodes, 2021- 2031F

6.2.3 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Radio-frequency Identification (RFID) Tags, 2021- 2031F

6.2.4 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Real-time Locating System (RTLS), 2021- 2031F

6.3 United States (US) Pharmaceutical Serialization Market, By End-Use

6.3.1 Overview and Analysis

6.3.2 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Pharma & Biological, 2021- 2031F

6.3.3 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Medical & Suppliers, 2021- 2031F

6.3.4 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Gloves, 2021- 2031F

6.3.5 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Scissors, 2021- 2031F

6.3.6 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Syringes & Needles, 2021- 2031F

6.3.7 United States (US) Pharmaceutical Serialization Market Revenues & Volume, By Surgical Tapes, 2021- 2031F

7.1 United States (US) Pharmaceutical Serialization Market Export to Major Countries

7.2 United States (US) Pharmaceutical Serialization Market Imports from Major Countries

8.1 Compliance rate with FDA serialization regulations.

8.2 Reduction in counterfeit drug incidents post-implementation of serialization.

8.3 Efficiency gains in supply chain operations due to serialization implementation.

9.1 United States (US) Pharmaceutical Serialization Market Opportunity Assessment, By Packaging Format, 2021 & 2031F

9.2 United States (US) Pharmaceutical Serialization Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 United States (US) Pharmaceutical Serialization Market Opportunity Assessment, By End-Use, 2021 & 2031F

10.1 United States (US) Pharmaceutical Serialization Market Revenue Share, By Companies, 2024

10.2 United States (US) Pharmaceutical Serialization Market Competitive Benchmarking, By Operating and Technical Parameters